24/7 Market News Snapshot 03 Apr, 2024 – Vanda Pharmaceuticals Inc. (NASDAQ: VNDA)
DENVER, Colo., 03 Apr, 2024 (247marketnews.com)- Vanda Pharmaceuticals(NASDAQ:VNDA) has shown significant bullish momentum today, opening at $4.65 and currently trading at $5.267 with a 34.696% increase from market open. The previous session close price of $3.910 has been surpassed, indicating potential upward trend continuation. The current trading volume of 42.7M suggests high investor interest. Technical analysis indicates strong buying pressure and potential further price increase. Traders may expect continued upward movement in the stock price based on the positive momentum. It is advisable to monitor the stock closely for a potential breakout or continuation pattern.
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com
Related news for (VNDA)
- Vanda Pharmaceuticals announces the publication in PLOS One of an article titled “Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial”
- Vanda Pharmaceuticals Announces FDA Granted Orphan Drug Designation for VGT-1849B, a Novel and Selective Candidate for the Treatment of Polycythemia Vera
- Vanda Pharmaceuticals Reports Second Quarter 2025 Financial Results
- Vanda Pharmaceuticals Announces First Patient Dosed in a Trial Evaluating VCA-894A in Charcot-Marie-Tooth disease Type 2S
- Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results